ACUTA CAPITAL PARTNERS LLC 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 3:32 pm Sale | 2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | ACUTA CAPITAL PARTNERS LLC | 0 0.000% | -391,209 (Position Closed) | Filing |
| 2022-02-15 2:51 pm Sale | 2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | ACUTA CAPITAL PARTNERS LLC | 391,209 5.900% | -24,290 (-5.85%) | Filing |
| 2021-03-22 06:06 am Purchase | 2021-03-12 | 13G | VistaGen Therapeutics, Inc. VTGN | ACUTA CAPITAL PARTNERS LLC | 415,499 8.400% | 165,499 (+66.20%) | Filing |
| 2021-02-16 06:14 am Purchase | 2020-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | ACUTA CAPITAL PARTNERS LLC | 250,000 5.400% | 250,000 (New Position) | Filing |